1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid has been researched along with kainic acid in 3 studies
| Studies (1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid) | Trials (1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid) | Recent Studies (post-2010) (1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid) | Studies (kainic acid) | Trials (kainic acid) | Recent Studies (post-2010) (kainic acid) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 9,540 | 3 | 1,775 |
| Protein | Taxonomy | 1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid (IC50) | kainic acid (IC50) |
|---|---|---|---|
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 4.2857 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 4.2857 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 4.2857 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 4.2857 | |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.0126 | |
| Glutamate receptor ionotropic, kainate 1 | Homo sapiens (human) | 0.077 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.0126 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.0126 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.0126 | |
| Glutamate receptor ionotropic, kainate 2 | Homo sapiens (human) | 0.077 | |
| Glutamate receptor ionotropic, kainate 3 | Homo sapiens (human) | 0.077 | |
| Glutamate receptor ionotropic, kainate 4 | Homo sapiens (human) | 0.077 | |
| Glutamate receptor ionotropic, kainate 5 | Homo sapiens (human) | 0.077 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.0126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krebs, JC; Wirtshafter, D | 1 |
| Meldrum, BS; Turski, L; Turski, WA; Watkins, JC | 1 |
| Chapman, AG; Hart, GP; Meldrum, BS; Turski, L; Watkins, JC | 1 |
3 other study(ies) available for 1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid and kainic acid
| Article | Year |
|---|---|
Control of food intake by kainate/quisqualate receptors in the median raphe nucleus.
Topics: Animals; Drinking; Eating; Glutamine; Injections; Kainic Acid; Male; Norleucine; Oxadiazoles; Piperazines; Quisqualic Acid; Raphe Nuclei; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
Evidence that antagonism at non-NMDA receptors results in anticonvulsant action.
Topics: Animals; Anticonvulsants; Aspartic Acid; Glutamates; Glutamine; Injections, Intraventricular; Kainic Acid; Male; Mice; N-Methylaspartate; Piperazines; Receptors, Amino Acid; Receptors, Cell Surface | 1987 |
Anticonvulsant activity of two novel piperazine derivatives with potent kainate antagonist activity.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Aspartic Acid; Chemical Phenomena; Chemistry; Glutamates; Kainic Acid; Mice; Mice, Inbred DBA; Mice, Inbred Strains; N-Methylaspartate; Oxadiazoles; Piperazines; Pyrrolidines; Quinolinic Acids; Quisqualic Acid; Seizures | 1985 |